ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,306.04
0.02%
Dow Jones
38,852.86
-0.55%
US Dollar vs MXN
16.7556
-0.24%
Brent Oil
84.525
0.24%
Bitcoin
67,817.70
-0.69%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Fortress Biotech Inc (FBIO)

  7. Fortress Biotech Inc (FBIO) Noticias

FBIO Fortress Biotech Inc

1.78
0.00 (0.00%)
Pre Mercado
Última actualización: 04:15:32
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Fortress Biotech Inc FBIO NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 1.78 04:15:32
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.78
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
16/5/202407:30GLOBEAvenue Therapeutics Announces Last Patient Last Visit in..
16/5/202407:00GLOBEFortress Biotech to Participate in the Alliance Global..
15/5/202415:15GLOBEFortress Biotech Reports First Quarter 2024 Financial..
15/5/202415:01GLOBEJourney Medical Corporation to Participate in the Alliance..
15/5/202407:30GLOBEAvenue Therapeutics Reports First Quarter 2024 Financial..
14/5/202407:30GLOBEFortress Biotech Announces First Patient Dosed in..
13/5/202415:01GLOBEJourney Medical Corporation Reports First Quarter 2024..
07/5/202407:30GLOBEJourney Medical Corporation to Announce First Quarter 2024..
02/5/202415:01GLOBEMustang Bio Announces Closing of $4 Million Public Offering
01/5/202415:01GLOBEJourney Medical Corporation Appoints Joseph Benesch as Chief..
29/4/202419:00GLOBEMustang Bio Announces Pricing of $4 Million Public Offering
29/4/202407:00GLOBEAvenue Therapeutics Announces Exercise of Warrants for $4.4..
25/4/202407:30GLOBEJourney Medical Corporation to Present at the Planet..
24/4/202406:30GLOBEAvenue Therapeutics Announces Reverse Stock Split
28/3/202415:05GLOBEFortress Biotech Reports 2023 Financial Results and Recent..
28/3/202408:00GLOBEMustang Bio Announces Vision for CAR T-Cell Therapy Platform..
25/3/202407:30GLOBEAvenue Therapeutics to Host Virtual Key Opinion Leader (KOL)..
21/3/202415:01GLOBEJourney Medical Corporation Reports Full-Year 2023 Financial..
18/3/202415:05GLOBEAvenue Therapeutics Reports Full Year 2023 Financial Results..
18/3/202407:30GLOBEJourney Medical Corporation Announces U.S. FDA Acceptance of..
15/3/202407:30GLOBEJourney Medical Corporation to Announce Year End 2023..
15/3/202407:15GLOBEAvenue Therapeutics Receives Positive Listing Determination..
13/3/202407:30GLOBEJourney Medical Corporation to Participate in the 36th..
12/3/202407:30GLOBEFortress Biotech to Participate in 36th Annual ROTH..
11/3/202407:30GLOBEJourney Medical Corporation Announces Presentation of Data..
11/3/202407:00GLOBEAvenue Therapeutics to Present BAER-101 Preclinical Data at..
07/3/202406:30GLOBEMustang Bio Announces Publication in Nature Medicine of Data..
04/3/202407:30GLOBEFortress Biotech and Cyprium Therapeutics Announce $4.1..
22/2/202407:30GLOBEAvenue Therapeutics Announces Publication in Drug..
11/1/202407:30GLOBEMustang Bio to Participate in the B. Riley Securities 4th..
11/1/202407:00GLOBEAvenue Therapeutics to Present at Sidoti January Micro-Cap..
05/1/202408:15GLOBEAvenue Therapeutics Enters into Warrant Exercise..
05/1/202407:30GLOBEJourney Medical Corporation Submits New Drug Application to..
04/1/202407:30GLOBEAvenue Therapeutics Reaches Final Agreement with the U.S...
03/1/202415:01GLOBEFortress Biotech Announces Closing of $11 Million Registered..
02/1/202415:05GLOBEJourney Medical Corporation Secures Credit Facility with SWK..
02/1/202407:30GLOBEAvenue Therapeutics Announces Completion of Enrollment in..
29/12/202307:20GLOBEFortress Biotech Announces Pricing of $11 Million Registered..
11/12/202307:30GLOBEMustang Bio Presents Updated Phase 1/2 Multicenter Clinical..
06/12/202307:30GLOBECyprium Therapeutics, a Fortress Biotech Subsidiary Company,..
06/12/202307:30PRNUSSentynl Therapeutics Completes Asset Transfer of CUTX-101..
06/12/202307:00GLOBEJourney Medical Corporation Announces Successful Completion..
01/12/202307:30GLOBEAvenue Therapeutics to Present at American Epilepsy Society..
14/11/202315:10GLOBEFortress Biotech Reports Third Quarter 2023 Financial..
14/11/202315:05GLOBEMustang Bio Reports Third Quarter 2023 Financial Results and..
14/11/202315:01GLOBEFortress Biotech Announces Closing of $10.0 Million Public..
13/11/202315:05GLOBEAvenue Therapeutics Reports Third Quarter 2023 Financial..
10/11/202307:15GLOBEFortress Biotech Announces Pricing of $10.0 Million Public..
09/11/202316:05GLOBEFortress Biotech Announces Launch of Proposed Public..
07/11/202315:01GLOBEJourney Medical Corporation Reports Third Quarter 2023..

Su Consulta Reciente

NASDAQ
FBIO
Fortress Biotech
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados